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Cells relay a plethora of extracellular signals to specific cellular responses using only a few second 
messengers, such as cAMP. To explain signaling specificity, cAMP-degrading phosphodiesterases 
(PDEs) have been suggested to confine cAMP to distinct cellular compartments. However, 
measured rates of fast cAMP-diffusion and slow PDE-activity render cAMP compartmentalization 
essentially impossible. Using fluorescence spectroscopy, we show that – contrary to earlier data 
– cAMP at physiological concentrations is predominantly bound to cAMP binding sites and, thus, 
immobile. Binding and unbinding results in largely reduced cAMP dynamics which we term 
'buffered diffusion'. With a large fraction of cAMP being buffered, PDEs can create nanometer-
sized domains of low cAMP concentrations. Using FRET-cAMP nanorulers we directly map cAMP 
gradients at the nanoscale around PDE molecules and the areas of resulting downstream 
activation of cAMP-dependent protein kinase (PKA). Our study reveals that spatiotemporal cAMP 
signaling is under precise control of nanometer-sized domains shaped by PDEs that gate the 









Hundreds of cell surface receptors, notably G protein-coupled receptors (GPCRs), signal via the 
second messenger cyclic adenosine 3’,5’-monophosphate (cAMP) and its effector proteins, in 
particular protein kinase A (PKA). This pathway is central to key physiological functions and, 
hence, also to many diseases, making it a highly attractive therapeutic target (Nikolaev et al., 2010, 
Gold et al., 2013, Zaccolo, 2009, Zaccolo, 2011, Perera and Nikolaev, 2013). However, it is 
unclear, how the huge number of receptors that all change global cellular cAMP levels can result 
in specific cellular responses. To explain receptor-specific responses observed in experiments and 
how these responses may differ in different regions of a cell, many researchers have proposed 
cAMP compartmentalization (Brunton et al., 1979, Hayes et al., 1980, Buxton and Brunton, 1983). 
The cAMP-degrading phosphodiesterases (PDEs) have been proposed to play a crucial role in 
establishing the cAMP gradients that are necessary to create such compartments (Houslay, 2010, 
Terrin et al., 2006, Mika et al., 2012, Stangherlin and Zaccolo, 2012).  
However, several studies have determined that cAMP is highly diffusible in intact cells (Bacskai 
et al., 1993, Nikolaev et al., 2004, Chen et al., 1999, Nikolaev et al., 2006, Richards et al., 2016, 
Agarwal et al., 2016, Huang and Gillette, 1993) and Table S1), and PDEs have low catalytic rates 
(Omori and Kotera, 2007, Conti and Beavo, 2007, Bender and Beavo, 2006). Therefore, cAMP 
should very rapidly equilibrate in a cell (Rich et al., 2000, Rich et al., 2001, Feinstein et al., 2012, 
Lohse et al., 2017, Xin et al., 2015), and this would prevent the existence of compartments with 
different concentrations of cAMP. Thus, the important question whether and how intracellular 




We therefore set out to address this controversy by developing tools and methods to directly 
measure and characterize cAMP mobility in intact cells and at physiological levels, and to measure 







cAMP buffering restricts cAMP dynamics in intact cells   
In order to visualize how signaling by cAMP is patterned, we aimed to develop and use new 
technologies that allow an analysis of cAMP diffusion and possible cAMP gradients at the 
nanometer scale. To assess intracellular cAMP diffusion under physiological conditions, we set 
out to directly measure cAMP dynamics in intact cells. We designed the cell-permeable, 
fluorogenic cAMP analog 8-(2-(5(6)-carboxyfluoresceindiacetate)-aminoethylthio)adenosine-
3',5'-cyclic monophosphate (hereafter, 8-FDA-cAMP) which becomes fluorescent when 
hydrolyzed to the corresponding fluorescein compound 8-F-cAMP by intracellular esterases 
(Figure 1A). A detailed characterization of this compound is given in Methods S1, including 
optical properties, equivalence to cAMP in binding to and activation of PKA as well as resistance 
to degradation by PDEs. 
The diffusion properties of this compound were then analyzed in intact cells by applying 
techniques that can report a wide range of diffusion speeds. Using a fluorescence fluctuation 
spectroscopy approach in combination with a confocal microscope, fast line-scan imaging of 
fluorescent molecules allows the precise extraction of diffusion coefficients ranging from below 
0.1 µm2/s up to hundreds of µm2/s (Ries et al., 2009, Hebert et al., 2005). (Figures 1B and S1; 
STAR Methods). Briefly, this approach yields the probability distribution function of an 
individual molecule occupying a given position in space and time (Spatiotemporal Image 
Correlation Spectroscopy (STICS) function): rapidly diffusing molecules can travel large distances 
in a short time, whereas bound or very slowly diffusing molecules persist at the same position for 




and binding, as schematically illustrated in Figure 1C. We calibrated the method using fluorescent 
compounds of known molecular weight, which yielded values in agreement with their theoretical 
diffusion coefficients in water (Figure S1).  
To analyze cAMP dynamics in intact cells, we used this technology in HEK293 cells loaded with 
low concentrations (<100 nM) of 8-FDA-cAMP (Figure S2). These experiments revealed that, at 
low cAMP levels, virtually all cAMP displays a pattern reflecting a bound, i.e. largely immobile, 
state of cAMP (Figures 1D and S2D). This can be qualitatively appreciated by the long-time tail 
of the STICS function (Figures 1C, 1D and S3). This observation is very striking, since several 
studies have uniformly reported that cAMP diffuses very fast in cells (see Table S1). In stark 
contrast, our data suggest that at basal concentrations cAMP dynamics is severely constrained in 
cells.  
Constrained cAMP diffusion in cells may be caused by cAMP binding to specific binding sites, 
resulting in ‘buffering’. To test whether such binding of 8-F-cAMP does indeed occur and would 
be overcome at higher cAMP concentrations by displacement from the binding sites, we stimulated 
HEK293 cells, after loading with 8-FDA-cAMP, with forskolin (fsk, 10 µM) and IBMX (100 µM) 
to maximally elevate intracellular cAMP levels. Analysis of cAMP dynamics under these 
stimulated conditions reveals a strikingly different spatiotemporal pattern: the long-time tail of the 
STICS function was largely lost, whereas a broader opening at shorter times was observed 
(Figures 1E, S2E, and S3). This fast component can also be appreciated by looking at diffusion 
coefficients extracted from the rapid time-scale of the Mean Square Displacement (MSD), and also 
by looking at the average transit time of the molecules over a distance of 1 µm (Figure 1F, S2E, 




stimulated cells, similar to the diffusion speed of fluorescein. This is in stark contrast to cells under 
unstimulated conditions where cAMP appears virtually immobile (Figure 1D, 1F).  
An alternative possibility to explain restricted cAMP diffusion might be geometrical diffusion 
constraints in cells (Richards et al., 2016). To rule out a contribution of such constraints, we 
collected STICS functions for 8-F-cAMP dynamics in cytosolic preparations under basal 
conditions (Figure 2A) and after saturating binding sites with unlabeled cAMP (Figure 2B). A set 
of reference molecules was used, spanning a range of molecular weights of approximately three 
orders of magnitude: fluorescein alone (≈0.3 kDa), EGFP (≈25 kDa) (Figure 2C) and Epac1-
camps-PDE4A1 (≈120 kDa) (Figure 2D). The diffusion coefficients obtained are displayed in 
Figure 2E as a function of their molecular weights. Based on the diffusion coefficient of the 
heaviest molecule (D = 27 ± 2 m2/s), we plotted the expected D values for the other molecules 
according to the Stokes-Einstein relationship, yielding the power law dependence D = MW-1/3 
(dashed line). Interestingly, all molecules followed the expected free diffusion behavior with the 
notable exception of 8-F-cAMP. Here, the values are more than twice below the expected diffusion 
coefficient, indicating binding to heavier components of the cytosolic extracts, in the approximate 
average range of 10-50 kDa (shaded area in Figure 2E). Strikingly, 8-F-cAMP recovered its free 
diffusion value upon addition of 100 M unlabeled cAMP to block all presumed cAMP-binding 
sites in the cytosolic preparations (Figures 2, S3).  
Such immobilization of cAMP requires high cAMP buffering capacity, and in fact, for the main 
cAMP effector PKA, such sites have been reported to occur in cell lysates in the low micromolar 
range (Walker-Gray et al., 2017). To quantify all cAMP binding sites, we estimated the buffering 




and determining the bound vs. free ratio with steady-state anisotropy measurements (STAR 
Methods, Figure S4). Measurements done at two different dilutions of the cytosolic preparations 
gave a range of cytosolic cAMP binding sites of 6-15 µM which is, as expected, larger than 
reported for PKA alone (Walker-Gray et al., 2017). The buffering capacity of entire cells 
(including particulate fractions such as membranes that are removed during cytosol preparations) 
is likely to be higher (Corbin et al., 1977). In our model, we make a conservative assumption of 
20 µM cAMP binding sites (Methods S2). 
Together, these data indicate very significant binding of cAMP to intracellular binding sites. Under 
basal conditions and concentrations, cAMP is mostly bound, but if it gets displaced, it diffuses 
fast, compatible with diffusion rates observed in earlier studies. 
PDEs generate nanometer-sized cAMP gradients in intact cells  
We and others have shown that observed cAMP gradients in cells require the effective diffusion 
of cAMP to be restricted by orders of magnitude compared to what has been measured so far (Rich 
et al., 2000, Rich et al., 2001, Feinstein et al., 2012, Lohse et al., 2017, Xin et al., 2015). Our 
findings on cAMP dynamics (Figures 1 and 2) show that such restricted diffusion dynamics 
during the spatial spread of cAMP signals does indeed exist because of cAMP buffering. We 
reasoned that the resulting reduction of free cAMP might resolve these discrepancies, because they 
might facilitate the generation of local cAMP gradients by PDEs. This would provide the first 
direct experimental evidence of local cAMP gradient formation.  
To visualize such gradients in intact cells and directly map their dimensions, we developed a set 




encoded constructs in this study are compiled in Figure S5M. These sensors are composed of the 
FRET-based cAMP sensor Epac1-camps (Nikolaev et al., 2004) and a PDE, separated by single-
alpha helical (SAH) domain linkers of defined nanometer length (Figures 3A and 3B). SAH 
domains are characterized by a modular sequence of ER/K amino acid repeats, resulting in a rod-
like shape – which makes them ideally suited to spatially separate two protein moieties at a defined 
distance (Sivaramakrishnan and Spudich, 2011). Stimulation of endogenous -adrenergic 
receptors (-ARs) with isoproterenol in intact HEK293 cells led to an increase in cytosolic cAMP 
as measured by Epac1-camps (Figure 3C). Tethering a PDE4A1 directly to Epac1-camps 
completely blunted the isoproterenol-induced FRET response (Figure 3E). This must be 
specifically due to the tethered PDE4A1 activity, because, first, the specific PDE4-inhibitor 
roflumilast induced a large and robust FRET change of the Epac1-camps-PDE4A1 sensor (Figure 
3E) and, second, stoichiometric overexpression of PDE4A1 with Epac1-camps without tethering 
them together still gave a robust (albeit dampened) FRET signal (Figures 3D and 3G). These data 
indicate that tethered PDE4A1 effectively depletes cAMP from the region surrounding the Epac1-
camps sensor. 
Strikingly, upon spatial separation of Epac1-camps and PDE4A1 by 10 nm (Epac1-camps-SAH10-
PDE4A1), isoproterenol-stimulation induced a FRET response of almost the same amplitude as 
that seen with stoichiometric overexpression of both proteins individually (Figures 3F and 3G). 
As expected, inhibition of PDE4 activity in all constructs eliminated cAMP gradients (Figure 3H). 
As controls to these experiments, we established that all constructs expressed equally well and that 
the described effects were similar at all expression levels (Figure S5E), and that fusion of neither 




does fusion of SAH10 to PDE4A1 reduce catalytic activity (Figure S5B-D). We also showed that 
the effect of tethered PDE4A1 was lost in a catalytically inactive mutant (Figure S5F and S5G). 
The highly significant differences between tethered and either non-tethered or spacer-separated 
PDE4A1 (Figure 3G) strongly indicate that PDE4A1 creates a region of low cAMP concentration 
with a radius which is clearly smaller than 10 nm. We therefore define this as a low cAMP 
nanodomain.  
Low cAMP nanodomains are PDE-subtype-specific  
We reasoned that the size of such low cAMP nanodomains might be determined by the type of 
PDEs. While the PDE4 family studied above comprises high-affinity (low micromolar), but low 
turnover (1-5 cAMP/s) enzymes, the PDE2 family represents the fastest enzymes with regard to 
cAMP degradation (Bender and Beavo, 2006). Therefore, we fused a truncated version of 
PDE2A3, PDE2cat, comprising only its catalytic domain (aa 578-941), to Epac1-camps, thereby 
generating Epac1-camps-PDE2cat. In line with the findings obtained with PDE4, tethered 
PDE2cat activity blunted the cAMP-FRET response to isoproterenol relative to Epac1-camps 
alone (Figures 4A vs 4C). Only upon specific inhibition of PDE2 with BAY 60-7550 did Epac1-
camps-PDE2cat detect an isoproterenol-mediated cAMP-increase (Figure 4C). Stoichiometric 
expression of both Epac1-camps and PDE2cat individually still led to a robust FRET signal upon 
isoproterenol stimulation (Figure 4B). These data confirm that also the tethered PDE2 activity 
generates a low cAMP nanodomain in its immediate vicinity (Figure 4E).  
We then designed another cAMP nanoruler, Epac1-camps-SAH30-PDE2cat, which records cAMP 
levels at 30 nm distance to PDE2cat (Figure 4D). In contrast to the observations with Epac1-




PDE2cat (Epac1-camps-SAH30-PDE2cat) (Figures 4D and 4E). As expected, inhibition of PDE2 
activity in all constructs eliminated cAMP gradients (Figure 4F). To account for the higher 
catalytic activity of PDE2cat relative to PDE4A1, the PDE2cat experiments were performed at 
lower expression levels (Figure S5H). Again, we also showed that Epac1-camps-PDE2cat and 
Epac1-camps-SAH30-PDE2cat sensors were not compromised with regard to either cAMP 
affinity (Figure S5I) nor PDE catalytic activity (Figure S5J-L).   
Combined, our data suggest that under basal conditions cells are able to buffer most of their cAMP. 
This, in turn, allows PDEs to generate low cAMP nanodomains. Only upon both, stimulation of 
ACs and inhibition of PDEs, is the level of cAMP raised sufficiently to overcome the capacity of 
the endogenous buffers and to progressively “flood” the small domains and ultimately entire cells.  
We then aimed to assess whether such low cAMP nanodomains might also be demonstrated in 
cytosolic preparations and to quantify the concentration threshold at which they might become 
“flooded”, because PDEs are no longer able to establish significant cAMP gradients (Figure 
5). Concentration-effect curves of cAMP-induced FRET changes of Epac1-camps are shown for 
the same conditions and constructs as used in cells for PDE4A1 (Figure 5A) and PDE2cat (Figure 
5B), and the resultant shifts of the EC50-values are given in Figure 5C. These data show for Epac1-
camps an apparent cAMP-affinity of 2.5 µM, which is shifted to 10-fold higher concentrations by 
tethered PDE4A1, while individual stoichiometric expression of Epac1-camps and PDE4A1 
caused an only 2-fold affinity shift (Figure 5A, C). In line with the results obtained in intact cells, 
separating PDE4A1 from Epac1-camps by 10 nm reduced the shift to almost the same level as 
stoichiometric expression, i.e., essentially abolishing the specific nanodomains (Figure 5A, C). 




the directly tethered PDE, and here, as in cells, a 30 nm spacer only partially reduced the shift 
(Figure 5B, C). Inspection of the curves shows that the shifts exist also at higher cAMP 
concentrations, suggesting that the low cAMP nanodomains become fully “flooded” only at high 
concentrations of cAMP.  
Low cAMP nanodomains control local PKA activity  
To investigate directly whether cAMP nanodomains translate into similarly targeted PKA 
signaling, we designed analogous targeted PKA activity reporters. Fusing PDE4A1 to the PKA 
FRET-sensor AKAR4 completely suppressed the detection of PKA activity in response to 
stimulation of HEK293 cells with isoproterenol, while AKAR4 alone gave a robust signal (Figures 
6A-D). This indicates that the PDE “protects” the PKA in its immediate vicinity from the cAMP-
stimulation. 
To demonstrate that PDEs shape local PKA gradients, we used full-length PDE2A3. The long N-
terminus of PDE2A3 should separate the catalytic center of the PDE from N-terminally fused 
sensors by several nanometers (Pandit et al., 2009). In fact, this construct allowed the respective 
sensors to again detect again isoproterenol-stimulated cAMP levels (Figure 6E) or PKA activity 
(Figure 6F). Interestingly, the constructs detected a comparable relative level of cAMP and of 
PKA activity (Figure 6G), strongly suggesting that the amount of cAMP at a given location in the 
cell dictates the degree of local PKA activity.   
As controls for these experiments we showed that only inhibitors of the relevant tethered PDE lead 




(Figure S6). These data confirm the specificity of our results and illustrate that individual PDEs 
regulate cAMP signaling specifically in their immediate vicinity. 
Model of cAMP signaling at the nanoscale 
To describe our findings in quantitative terms, we use a biophysical model for the formation of 
cAMP gradients by PDEs at the nanoscale (Methods S2). Based on our experimental observations 
(Figures 1-3, S4) this model analyzes the effects of binding sites on free cAMP concentrations in 
cells and on the spatial profile of cAMP gradients generated by PDE-mediated degradation.  
The model confirms that cAMP gradients around PDEs are of nanometer size (see Figure 7B, 
Methods S2). Figure 7B illustrates the free cAMP concentration at a distance from the PDE4A1 
(in red) superposed to the experimental free cAMP concentration ranges measured using our FRET 
sensors at the PDE, 10 nm away, and in the bulk of the cytosol. The concentration gradient follows 
the equation [cAMP]= [cAMP]bulk(1-R0/r), where [cAMP] denotes the concentration of free 
cAMP, [cAMP]bulk the concentration of free bulk cAMP far from the PDE, r the distance from the 
PDE catalytic site, and R0 is a radius where [cAMP] would be equal to zero. This radius R0 relates 
not only to the geometrical size of the PDE but also to the flux of cAMP, i.e. the rate of degradation 
at the “sink” (see Methods S2).  
Moreover, based on the cAMP concentration transients we obtain upon inhibition of PDE4A1 (see 
e.g. Figure 3E), we can infer a turnover number of ~320 molecules/s. To assess whether these 
PDE turnover rates are compatible with the model, we concomitantly addressed the question 
whether PDE4A1 exists in cells as mono- or oligomers. Molecular brightness analysis, a technique 




PDE4A1 is largely dimeric (in contrast to Epac1-camps alone; Figure S7). Therefore, our 
experiments and the biophysical model uniformly demonstrate that a single PDE4 has a turnover 
number of ~160 molecules cAMP/s in intact cells, which is sufficient to deplete a nanometer-sized 







Despite a wealth of indirect evidence that cAMP compartments might exist in cells and should be 
under the control of PDEs, the molecular basis of how cAMP might be sequestered in cells has 
remained unknown for decades. Here, we provide the molecular mechanisms of such cAMP 
compartmentation at the nanoscale. 
Our data introduce the novel concept that cellular cAMP is governed by catch-and-release or 
‘buffered’ dynamics (Figure 7A). Under basal conditions, cAMP is mostly bound and effectively 
diffuses very slowly, if at all, and its free concentration is well below the levels of total cAMP, i.e. 
the levels measured by usual biochemical assays. When cAMP molecules are released from the 
binding sites, they diffuse fast – compatible with diffusion rates observed previously – but become 
re-captured quickly by the next cAMP binding proteins (Figure 7A, left panel). This is entirely 
compatible with earlier experiments, by us (e.g. (Nikolaev et al., 2004)) and others (Table S1), 
showing that rapid diffusion refers to the first time point at which a stimulus can be noticed in 
different areas of a cell; however, the corresponding signals continue to increase for long times 
afterwards, compatible with both continued production of cAMP and its slow effective diffusion. 
The experimental approach that we apply here has the advantage of using, for the first time, only 
trace amounts of fluorescent cAMP, not only allowing direct tracking of cAMP dynamics (as 
opposed to indirect tracking using FRET reporters), but also allowing measurements at or near 
basal cAMP levels, which permits us to clearly demonstrate buffered diffusion. 
When cAMP levels are increased, for example by receptor stimulation, the binding sites become 
progressively saturated, free cAMP increases and diffusion occurs first from one binding site to 




right panel). Buffering of the initial cAMP wave ensures that free cAMP levels are kept in a range 
which then permits individual PDEs to create and “defend” a nanometer-sized space around them 
with an even lower concentration of cAMP, allowing effectors such as PKA to be “protected” from 
external cAMP-mediated stimuli within these nanometer-sized domains. Under these conditions, 
our data indicate that PDE catalytic rates are sufficient to metabolize the few free cAMP molecules 
that are present in these small volumes; when the ambient cAMP concentrations increase, the low 
cAMP domains become smaller. The downstream consequence of these nanometer-sized regions 
of low cAMP is that PKA (and presumably other cAMP effectors) remain insensitive to cAMP 
signals until cAMP is increased to levels that are sufficient to progressively fill these regions (see 
Figure 7A).  
For our buffered diffusion model to hold, the requirement is that the buffering capacity of the 
cytoplasm is sufficient. In agreement with recent determinations (Walker-Gray et al., 2017) we 
directly determined the number of cytosolic cAMP binding sites to be in the range of 6-15 µM. It 
has been shown that ~30-50% of the total cellular PKA are immobile and associated with the 
particulate fraction which we remove during our cytosol preparations (Corbin et al., 1977). Hence, 
the total amount of cAMP binding sites in cells is likely to be even higher than quantified here in 
cytosolic preparations. The discovery of the biomolecular condensates described in a companion 
manuscript strikingly illustrates additional “sponges” for cAMP (Zhang et al., accompanying 
manuscript) which effectively increase the buffering capacity of the cell. Together, these sites are 
sufficient to very significantly buffer cellular cAMP levels - much alike the buffering of 
intracellular calcium, where also a large number of bindings sites reduce the free concentration 




Calculation of a concentration gradient around a single PDE4A1, based on the Smoluchowski 
model (Smoluchowski, 1916, Rice, 1985) (Methods S2), shows that a nanometer-sized region of 
significantly lowered cAMP does indeed occur (Figure 7B). Given the largely dimeric PDE4A1 
structure, our data therefore indicate that the measured cAMP concentration values in the bulk and 
at the tethered FRET-sensor are in agreement with an individual PDE4A1 turnover rate of about 
160 molecules/s. Although this is higher than values reported for the purified enzyme (Bender and 
Beavo, 2006), these latter values may well be reduced due to damage during purification, while 
ours are some of the first data providing individual PDE4 turnover rates in intact cells, and as such 
not conflict with previous literature values. In fact, in intact cells, very high PDE activities have 
already been reported (Nikolaev et al., 2005). The excellent agreement of the data of the cAMP 
measurements in intact cells and in cytosolic preparations (see Methods S2) further supports this 
conclusion.  
The agreement of the size of low cAMP nanodomains with that of the PKA activity measured with 
the AKAR4 sensor suggests that nanometer-sized PDE domains indeed modulate downstream 
target activation and may represent functional modules of cAMP signaling. The demonstration of 
such functional cAMP and PKA nanodomains is further in line with recent observations by super-
resolution microscopy of PKA signaling hot-spots with a diameter of 100-200 nm (Mo et al., 
2017). To constrain PKA activity to such small domains requires that its catalytic subunit is either 
rapidly recaptured by the regulatory subunits after activation (Mo et al., 2017, Walker-Gray et al., 
2017), or that PKA can function as an intact holoenzyme (Smith et al., 2017). 
Our data with PDE2 demonstrate that longer-range effects of PDEs may also be possible, both for 
cAMP and PKA signals. The mechanisms of these longer range effects needs to be explored 




fact that in these experiments we used only isolated catalytic domains of PDE2, unlikely to remain 
immobile in intact cells because of lack of targeting domains) or of more complex arrangements. 
However, the excellent agreement of the data from intact cells and cytosolic preparations suggests 
that these observations are indeed a property of our PDE2 constructs. 
Our demonstration of sharp concentration gradients along with a direct translation into graded 
PKA activity explains how cAMP can act very locally, and thus trigger responses spatially limited 
at the nanometer scale. The very small size of cAMP domains strongly suggests that 
compartmentalized cAMP signaling is controlled in a stochastic manner by individual molecules 
of cAMP. This spatially tight control provides the basis for the physiologically important 
specificity of cAMP signaling. Disruption of local cAMP signaling has been suggested to be 
associated with a variety of diseases (Gold et al., 2013) such as heart failure (Nikolaev et al., 2010) 
and cancer (Zhang et al., companion manuscript). The elucidation of the molecular basis of cAMP 
compartmentation now permits to link disruption of cAMP compartmentation to disease and, thus, 
to explore novel therapeutic strategies that are based on a cell’s ability to orchestrate cAMP 
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FIGURES AND LEGENDS: 
 
Figure 1. cAMP dynamics are highly restricted in intact cells.  (A) Molecular structure 
of fluorogenic 8-FDA-cAMP. Arrows highlight sites where intracellular esterases cleave both 
ester bonds. (B) Linescan approach used in our experiments. The focused laser beam (blue 
ellipsoids) is repeatedly scanned along the cell cytosol, giving rise to a kymograph containing the 
8-FDA-cAMP fluorescence fluctuations (see STAR Methods) (C) Two simulated STICS 
functions are schematically illustrated, referring to fast (100 µm2/s) diffusion rates combined with 
binding (left) and fast diffusion rates alone (right). x-axis refers to the spatial, y-axis to the 
temporal dimension. (D) Average STICS function (11 different cells, three independent 
experiments) measured in the cytoplasm of intact HEK293 cells loaded for 30 min with 
100 nM 8-FDA-cAMP under basal conditions. (E) Average STICS function (9 different cells, 
three independent experiments) measured in the cytoplasm of intact HEK293 cells loaded for 30 
min with 100 nM 8-FDA-cAMP and stimulated for 5 min with fsk (10 µM)/IBMX (100 
µM). (F) Measured diffusion coefficient in HEK293 cells extracted from the slope of the MSD in 
the range of 0-0.5 ms for FDA, 8-FDA-cAMP (from panel D) and 8-FDA-cAMP stimulated 
with fsk + IBMX (from panel E). Error bars are standard deviations. 
Figure 2. cAMP dynamics are buffered via cAMP binding sites. Average STICS function 
measured in a cytosol preparation of (A) HEK293 cells loaded for 30 min with 100 nM 8-FDA-
cAMP (n=8). (B) as in (A) after the addition of unlabeled cAMP (100 µM) (n=6). (C) HEK293 
cells expressing EGFP (n=6) and (D) HEK293 cells expressing the fusion protein Epac1-camps-
PDE4A1 (n=4). (E) Relationship between molecular weight and diffusion coefficients. Orange 




(Eq. 1, STAR Methods) derived from panels (A-D) and FDA alone. The diffusion coefficients 
are plotted against the molecular weight of each compound. Red dots represent the theoretical 
diffusion coefficients based on the Stokes-Einstein relation 𝐷 =
𝐾𝑇
6𝜋𝜂𝑅
. The power law dependence 
on the molecular weight (exponent = -0.3) is superimposed to the data as a blue dotted line.   
Figure 3. Genetically-encoded nanorulers map cAMP gradients around single PDE 
molecules in intact cells. (A,B) Design of FRET-based nanorulers to identify low cAMP 
nanodomains in intact cells. Tethering the FRET-based cAMP sensor Epac1-camps to a PDE 
allows measuring cAMP concentrations in the direct vicinity of a single PDE molecule (A). 
Incorporation of nanometer linkers based on single alpha helical domains between Epac1-camps 
and a PDE allows measuring the cAMP gradient at defined distances away from the PDE (B). (C) 
Isoproterenol (Iso, 10 µM) stimulation leads to an increase in cAMP levels which are detected by 
Epac1-camps (note upward-reflected trace). (D) When Epac1-camps and PDE4A1 are expressed 
at equimolar levels but not tethered, a rise in cAMP levels is still detected upon Iso stimulation. 
(E) However, when tethering PDE4A1 to Epac1-camps (which measures cAMP levels in direct 
vicinity of PDE4A1), no rise in cAMP is detected upon Iso stimulation. (F) Separating Epac1-
camps and PDE4A1 with a 10 nm linker leads to a similar response than observed in the equimolar 
expression in (D). (C-F) Average traces of corrected and normalized FRET ratios in HEK293 cells 
transfected with Epac1-camps (C), Epac1-camps-IRES2-PDE4A1 (i.e. individual but roughly 
equimolar expression of sensor and PDE) (D), Epac1-camps-PDE4A1 (= tethered) (E), and Epac1-
camps-SAH10nm-PDE4A1 (=10 nm distance) (F), treated consecutively with isoproterenol (Iso, 
10 µM), the PDE4-inhibitor roflumilast (300 nM), and fsk (10 µM)/IBMX (100 µM). Traces are 
representative for 8, 13, 19, and 14 independent experiments, respectively. The solid lines indicate 




stimulation upon fsk/IBMX treatment (set to 100%). The inset in (C) shows the normalized, 
isoproterenol-induced FRET ratios from all cells expressing Epac1-camps (n=34). (G,H) 
Normalized, isoproterenol-induced (G) or roflumilast-induced (H) FRET ratios pooled from all 
cells measured as in (D-F). n=63 (Epac1-camps-IRES2-PDE4A1), 56 (Epac1-camps-PDE4A1), 
and 51 (Epac1-camps-SAH10nm-PDE4A1) cells. The columns represent means, the vertical bars 
s.e.m. ****P<0.0001, one-way analysis of variance (ANOVA, Tukey’s post-test), n.s. not 
significant.   
Figure 4. Low cAMP nanodomains are PDE-subtype-specific. (A) Iso stimulation leads to an 
increase in cAMP levels which are detected by Epac1-camps (note upward-reflected trace). (B) 
When Epac1-camps and PDE2cat are expressed at equimolar levels but not tethered, a rise in 
cAMP levels is still detected upon Iso stimulation. (C) However, when tethering PDE2cat to 
Epac1-camps, no rise in cAMP levels is detected upon Iso stimulation. (D) Separating Epac1-
camps and PDE with a 30 nm linker leads to almost no Iso-induced FRET response similar to what 
is observed in (C). (A-D) Average traces of corrected and normalized FRET ratios in HEK293 
cells transfected with Epac1-camps (A), Epac1-camps-IRES2-PDE2cat, leading to individual but 
roughly equimolar expression of the two proteins (B), Epac1-camps-PDE2cat (tethered) (C), and 
Epac1-camps-SAH30nm-PDE2cat (D), treated consecutively with isoproterenol (Iso, 10 µM), the 
PDE2-inhibitor BAY 60-7550 (100 nM), and fsk (10 µM)/IBMX (100 µM). Traces are 
representative for 3, 10, 11, and 14 independent experiments, respectively. The inset in (A) shows 
the normalized, isoproterenol-induced FRET ratios from all cells expressing Epac1-camps (n=12). 
The solid lines indicate the mean, shaded areas s.e.m. FRET traces are normalized to baseline (set 
to 0%) and maximal stimulation upon fsk/IBMX treatment (set to 100%). (E,F) Normalized, 




measured as in (B-D). n=28 (Epac1-camps-IRES2-PDE2cat), 30 (Epac1-camps-PDE2cat), and 25 
(Epac1-camps-SAH30nm-PDE2cat) cells. The columns represent means, the vertical bars s.e.m. 
****P<0.0001, ***P<0.001 one-way analysis of variance (ANOVA, Tukey’s post-test), n.s. not 
significant.   
Figure 5. Low cAMP nanodomains stay intact in cytosolic cell preparations and become 
‘flooded’ at micromolar cAMP. (A,B) Shown are concentration-effect curves of cAMP-induced 
changes in FRET ratio normalized to buffer (set to 0%) and 1 mM cAMP (set to 100%). (A) 
Tethering PDE4A1 (blue curve) to Epac1-camps (black curve) leads to a pronounced right-shift 
of the concentration-effect curve, much more than stoichiometric overexpression of Epac1-camps 
and PDE4A1 (+PDE4A1, green curve). The difference in the EC50-values between the green 
(global PDE activity) and blue curves (local PDE activity) is a biochemical equivalent to the cAMP 
nanodomain. Separating Epac1-camps and PDE4A1 by 10 nm (Epac1-camps-SAH10nm-
PDE4A1) does not generate a low cAMP nanodomain (turquoise curve). Note that the turquoise 
curve (cAMP at 10 nm distance from the PDE) and the green curve (global PDE activity) are 
superimposable. (B) Tethering PDE2cat (red curve) to Epac1-camps (black curve) leads to a 
pronounced right-shift of the concentration-effect curve, significantly more than individual 
stoichiometric expression of Epac1-camps and PDE2cat (yellow curve). Separating Epac1-camps 
and PDE2cat by 30 nm (Epac1-camps-SAH30nm-PDE2cat, orange curve) only partially restores 
the cAMP gradient. Note that the orange line (cAMP at 30 nm distance from the PDE) is in 
between the dashed yellow (global PDE activity) and red lines (local PDE activity). Data in (A,B) 
are means ± s.e.m. of at least three independent experiments. (C) Apparent cAMP EC50 values 
derived from the data in (A, B). The mean EC50 of Epac1-camps is shown as a solid black line. 




PDE4A1/PDE2cat expressed separately (+), with tethered PDE4A1 or PDE2cat, respectively 
(tethered), and at a distance of 10 and 30 nm from the PDEs (10 nm and 30 nm). Error bars show 
the 95% confidence intervals of the mean. 
Figure 6. Low cAMP nanodomains dictate local PKA activity. (A) Design of nanodomain-
targeted PKA activity reporters. (B-D) The PDE4A1/cAMP nanodomain completely blunts local 
PKA-dependent phosphorylation. Average traces of corrected and normalized FRET ratios in 
HEK293 cells transfected with AKAR4 (B) and AKAR4-PDE4A1 (C), treated consecutively with 
isoproterenol (Iso, 10 µM), roflumilast (300 nM, in (C) only), and fsk (10 µM)/IBMX (100 µM). 
Traces are representative for 3 and 5 independent experiments, respectively. The solid lines 
indicate the mean, shaded areas the s.e.m. FRET-traces are normalized to baseline (set to 0%) and 
maximal stimulation upon fsk/IBMX treatment (set 100%). (D) Normalized, isoproterenol-
induced FRET ratios pooled from all cells measured as in (B,C). n=20 (AKAR4) and 22 (AKAR4-
PDE4A1) cells. The horizontal bars represent means, the vertical bars s.e.m. ****P<0.0001, 
unpaired t-test. (E-G) Local cAMP pools spatially overlap with local PKA phosphorylation. (E, F) 
Average time courses of corrected and normalized FRET ratios in HEK293 cells transfected with 
Epac1-camps-PDE2A3 (E) and AKAR4-PDE2A3 (F), treated consecutively with isoproterenol 
(Iso, 10 µM), BAY 60-7550 (100 nM), and fsk (10 µM)/IBMX (100 µM). Time courses are 
representative of 8 and 7 independent experiments, respectively. The solid lines indicate the mean, 
shaded areas s.e.m. FRET traces are normalized to baseline (set to 0%) and maximal stimulation 
upon forskolin/IBMX treatment (set to 100%). (G) Normalized, isoproterenol-induced FRET 
ratios pooled from all cells measured as in (E,F). n=32 (Epac1-camps-PDE2A3) and 35 (AKAR4-





Figure 7. Model of cAMP signaling at the nanoscale. (A) Schematic illustration of buffered 
diffusion of cAMP and formation of low cAMP nanodomains under basal (left) and stimulated 
conditions (right). The presence of a large concentration of cAMP binding sites (illustrated as 
honeycombs) (Figure S4) lowers the concentration of free cAMP (red dots). The low 
concentration of free cAMP enables phosphodiesterases to establish nanometer-sized domains 
where the local cAMP concentration is decreased to a range below the activation threshold of local 
cAMP effectors (lower panels). Upon stimulation (right panel), cAMP binding sites become 
progressively saturated and, as a consequence, the width and depth of these nanodomains is 
decreased, eventually leading to “flooding” and activation of local cAMP effectors. (B) The spatial 
cAMP concentration profile (red line) around a PDE4A1 molecule as inferred from experiments 
(Figure 3) and quantitative considerations (Methods S2). The red line shows the free cAMP 
concentration profile generated by a PDE4A1 dimer with a turnover rate of ~160 
molecules/s/PDE4A1. The gray shaded area illustrates the range of possible profiles from 
experimental values (Methods S2). The open blue circles represent the measured mean values of 
free cAMP concentration at the PDE4A1 (data from Figure 3E), at 10 nm distance of the PDE 
(data from Figure 3F), and in bulk cytosol (data from Figure 3D). Error bars represent 95% 
confidence intervals. The black line indicates the cAMP concentration profile around a perfect 




SUPPLEMENTAL FIGURE TITLES AND LEGENDS 
 
Figure S1. Related to Figures 1 and 2. Concept for measuring diffusion coefficient of a 
fluorescent species based on sequential rapid linescans and STICS measurement of the 
diffusion of a set of reference molecules of known molecular weight in water: experiments 
and theory. (A) Simulated STICS function derived for a species undergoing free diffusion in 3D 
at a rate of 50 µm2/s, (B) 1 µm2/s and (C) 0.1 µm2/s. (D) Measured (Gaussian) profiles of the 
STICS functions in (A) and (C) at four different times highlighted by the dashed lines, namely 1 
ms (red), 10 ms (yellow), 100 ms (green) and 1 s (blue). (E) From the broadening of the Gaussians 
measured at increasing time lags, it is possible to reconstruct a MSD (eq. 1). (F) This approach is 
graphically summarized using a color code referring to the curves in (D). (G) Vertical cross 
sections of the STICS functions in (A), illustrating the shift to the right of the distribution of arrival 
times as the diffusion coefficient is reduced from 50 µm2/s to 0.1 µm2/s. (H) Average STICS 
functions (3 independent experiments) of 100 nM fluorescein, 100 nM 20kDa fluorescein-dextran, 
100 nM 70kDa fluorescein-dextran and of 100 nM 250kDa fluorescein-dextran measured in water. 
The pH was set to pH=9 using NaOH and the measurements performed at room temperature (T=25 
°C). (I) Least-squares one-diffusion component fit (eq. 1) of the STICS functions displayed in (H). 
(J) Mean squared displacement (MSD) from the STICS functions in (H) (with exception of 
fluorescein, which is too fast for this line by line fitting and eq. 1 was used). (K) Distribution of 
arrival times over a distance of 1 µm for FDA, 20 kDa, 70 kDa, 250 kDa fluorescein-dextran 
molecules respectively. 
(L) Red crosses display diffusion coefficients extracted from the data displayed in (H) as a function 
of the molecular weight.  Blue circles represent the predicted diffusion coefficients for these 




Figure S2. Related to Figure 1. Cellular uptake kinetics and distribution of FDA and 8-FDA-
cAMP and multi-scale cAMP dynamics in intact cells.  (A) Fluorescence intensity time course 
recorded in a Neo2 plate reader (see STAR Methods) from a population of HEK293 cells 
incubated with 100 nM FDA (red), 100 nM 8-FDA-cAMP (blue), or HBSS (black), respectively.  
(B) Confocal and corresponding DIC images of HEK293 cells loaded with 100 nM of 8-FDA-
cAMP (B) or 100 nM FDA (C) after 30 minutes of incubation and washout in HBSS. Scale bars 
are 10 µM. (D) The broadening of the STICS function in Figure 1D (basal) as a function of time 
is recorded by displaying its horizontal cross sections at selected time points, as indicated by the 
color scale. (E) Same as in (D), for the STICS functions in Figure 1E (stimulated, i.e. fsk (10 
µM)/IBMX (100 µM). (F) Distribution of average molecular arrival times extracted from the 
vertical profiles of Figures 1D and 1E at a distance of 1 µm. (G) MSD for the basal and fsk/IBMX 
stimulated case for the 0-2 ms range. (H) Simulated STICS function for the combined diffusion of 
a fast (150 µm2/s) and a slow (0.1 µm2/s) components and (I) resulting MSD with linear fits to the 
two components: fast (blue), slow (red). 
 
Figure S3. Related to Figures 1 and 2. STICS functions of 8-FDA-cAMP in intact HEK293 
cells and cytosolic preparations. (A) Shown are nine representative STICS functions for 8-F-
cAMP dynamics in HEK293 cells under basal conditions. (B) Shown are nine representative 
STICS functions for 8-F-cAMP dynamics in HEK293 cells after 5 minutes stimulation with fsk 
(10 µM)/IBMX (100 µM). (C) Representative STICS functions for 8-F-cAMP dynamics in 
HEK293 cell cytosolic preparations in basal conditions and (D) after addition of 100 µM unlabeled 
cAMP. (E) 2D least squares fit to the STICS functions reported in Figures 2A-2D using eq. 1. The 





Figure S4. Related to Figures 2 and 7. Quantification of the buffering capacity of cytosolic 
preparations using anisotropy. Cytosolic preparations were prepared (STAR Methods) and 
diluted in binding buffer (20 mM MOPS, 150 mM NaCl, 0.005 % CHAPS, 0.5 mM IBMX, pH 7) 
(for details on dilutions see STAR Methods). Increasing amounts of 8-F-cAMP lead to a decrease 
in anisotropy values, both in the 60x and 1500x diluted cytosolic preparations. The reduction in 
anisotropy is ascribed to the increasing ratio of free 8-F-cAMP vs bound 8-F-cAMP (at low 
concentrations of 8-F-cAMP, essentially all 8-F-cAMP is bound (measured by high anisotropy 
values) because the concentration of the dye is well below the concentration of the cAMP binding 
sites (i.e. the buffering capacity) in the cytosolic preparation). At increasing concentrations of 8-
F-cAMP the buffering capacity of the cytosolic preparation is exceeded, and the anisotropy values 
decrease towards those of free 8-F-cAMP. Data are normalized to the maximal anisotropy value 
in order to account for the different anisotropy values observed at the two different dilutions of 
cytosolic preparations. Fluorescein alone does not display any binding. Solid lines connecting the 
mean values are meant as a guide for the eye. Data are mean  s.e.m. from three independent 
experiments. 
 
Figure S5. Related to Figures 3 and 4. Affinities, catalytic activities and expression levels of 
FRET biosensors. (A-D) PDE4A1 sensors are neither compromised in cAMP affinity nor 
catalytic PDE activity. (A) Tethering PDE4A1 (blue) or SAH10-PDE4A1 (turquoise) to Epac1-
camps (black) does not change the affinity of the sensor for cAMP. Shown are concentration effect 
curves of the normalized emission ratios (480/525 nm) obtained from cytosolic fractions of 




presence of the indicated cAMP concentrations. Data are means s.e.m. of at least 3 independent 
experiments. (B,C) The catalytic activity of PDE4A1 is not altered when tethered to Epac1-camps 
(B) or Epac1-camps-SAH10 (C). Data show one representative (out of 6-9) emission ratios 
(CFP/FRET) measured over time in cytosolic fractions of transfected HEK293 cells. Addition of 
100 µM cAMP (black arrow) leads to an increase in the emission ratio which is transient due to 
PDE4A1 activity. (D) The ‘dwell’ times (t; mean s.e.m.) are a surrogate parameter for PDE 
activity and are not significantly different in the two constructs, according to an unpaired t-test. 
(E) Dependence of FRET-responses to isoproterenol on PDE4A1 expression levels. Shown are 
normalized FRET ratios (CFP/FRET) upon isoproterenol (10 µM) stimulation of HEK293 cells 
transiently transfected with the indicated constructs, normalized to the maximum response elicited 
upon fsk (10µM)/IBMX (100 µM) stimulation. Data points show isoproterenol responses from all 
cells measured in Figure 3. Only cells expressing the respective sensor at expression levels 
resulting in YFP emission values of 1500-4000 were used for the analysis. In this range, sensor 
expression has only a slight negative effect upon isoproterenol responses. Green: Epac1-camps + 
PDE4A1, blue: Epac1-camps-PDE4A1, turquoise: Epac1-camps-SAH10-PDE4A1. (F, G) A 
fusion protein of Epac1-camps and a catalytically-dead PDE4A1 (D352A) senses cAMP. (F) 
Epac1-camps-PDE4A1 (D352A) senses cAMP increases upon Iso stimulation. Shown is 
an average trace from one representative coverslip (3 cells) of corrected and normalized FRET 
ratios in HEK293 cells transiently transfected with the indicated construct. The solid line indicates 
the mean, shaded areas the s.e.m. Cells were treated consecutively with isoproterenol (Iso, 10 µM), 
the PDE4-inhibitor roflumilast (300 nM) and forskolin (fsk, 10 µM)/IBMX (100 µM). An increase 
in FRET, which is comparable to the experimental data of Epac1-camps (c.f. Figure 3C), was 




normalized to FRET responses induced by fsk/IBMX (set as 100 %). Data are means ± SD from 
11 cells. (H) Dependence of FRET-responses on PDE2cat expression levels. Shown are 
normalized FRET ratios (CFP/FRET) upon isoproterenol stimulation of HEK293 cells transiently 
transfected with the indicated constructs, normalized to the maximum response elicited upon fsk 
(10 µM)/IBMX (100 µM) stimulation. Data points show isoproterenol responses from all cells 
measured in Figure 4. Only cells expressing the respective sensor at expression levels resulting in 
YFP emission values of 25-800 were used for the analysis. In this range, sensor expression has 
only a slight negative influence upon isoproterenol responses, while FRET changes could still be 
robustly detected. Yellow: Epac1-camps + PDE2cat, red: Epac1-camps-PDE2cat, orange: Epac1-
camps-SAH30-PDE2cat. (I-L) PDE2cat sensors are neither compromised in cAMP affinity nor 
catalytic PDE activity. (I) Tethering PDE2cat (red) or SAH30-PDE2cat (orange) to Epac1-camps 
(black) does not change the affinity of the sensor for cAMP. Shown are concentration-effect curves 
of the normalized emission FRET ratios (480/525 nm) obtained from cytosolic fractions of 
HEK293 cells expressing the indicated constructs (pre-incubated with the PDE2-inhibitor EHNA 
(100 µM) in the presence of indicated cAMP concentrations. Data are means s.e.m. of at least 3 
independent experiments. (J,K) The catalytic activity of PDE2cat is not altered when tethered to 
Epac1-camps (J) or Epac1-camps-SAH30 (K). Data show one representative (out of 7) emission 
ratios (CFP/FRET) measured over time in cytosolic fractions of transfected HEK293 cells. 
Addition of 100 µM cAMP (black arrow) leads to an increase in the emission ratio which is 
transient due to PDE2cat activity. (L) The ‘dwell’ times (t; mean s.e.m.) are a surrogate 
parameter for PDE activity and not significantly different in both constructs, according to an 
unpaired t-test. (M) Confocal images of all FRET-based biosensors used in this study. Indicated 




construct (excited using direct EYFP excitation at 514 nm) is displayed next to the Differential 
Interference Contrast image (DIC). Scale bar is 10 µm. For single-cell FRET experiments, regions 
of interest (ROIs) were selected taking care to analyze only regions of homogeneous expression 
(see example in panel M). 
 
Figure S6. Related to Figure 6. PDE4A1 and PDE2A3 abolish PKA activity only in their 
immediate vicinity. (A-C) Inhibition of local PDE4A1 activity with the PDE4-inhibitor 
roflumilast leads to strong local PKA activity in the PDE nanodomain (A, also cf Figure 6) 
whereas treatment with the PDE2-inhibitor BAY 60-7550 has no effect (B, C). (D-F) Inhibition of 
local PDE2A3 activity with the PDE2-inhibitor BAY 60-7550 leads to strong local PKA activity 
in the PDE nanodomain (D, also cf Figure 6) whereas treatment with the PDE4-inhibitor 
roflumilast has no effect (E, F). Shown are representative traces of normalized FRET ratios 
measured in HEK293 cells transiently transfected with AKAR4-PDE4A1 (A-C) and AKAR4-
PDE2A3 (D-F). Cells were treated consecutively with indicated compounds (isoproterenol (Iso, 
10 μM), PDE-inhibitors (PDE4: roflumilast (300 nM), PDE2: BAY 60-7550 (100 nM)), and fsk 
(10 μM)/IBMX (100 μM)). Traces show one representative coverslip with (A) 6 cells, (B) 7 cells, 
(C) 5 cells, (D) 4 cells, (E) 3 cells and (F) 4 cells out of three independent experiments. Solid lines 
indicate the mean, shaded areas the s.e.m. 
 
Figure S7. Related to Figure 7. Characterization of the oligomerization state of PDE4A1.  
Shown are molecular brightness data of HEK293 cells transiently expressing Epac1-camps-
IRES2-PDE4A1 (stoichiometric expression of Epac1-camps and PDE4A1, red circles) or Epac1-




camps (measured by direct excitation of EYFP at 514 nm), which defines the monomeric state is 
2324 photon counts/molecule/s, whereas the average molecular brightness of Epac1-camps-
PDE4A1 is 5009 photons/molecule/s, indicating on average a dimer or higher order oligomers. 
Red circles and blue rectangles correspond to one measurement of one intact cell. Three separate 
transfections were investigated for each construct. Solid black lines represent the mean, error bars 
s.e.m. 
Table S1. Related to Figures 1 and 2.  cAMP diffusion coefficients (in µm2/s) in living cells 
reported in the literature 


















RESOURCE AVAILABILITY  
Lead Contact  
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead contact, Martin J. Lohse (m.lohse@mdc-berlin.de).  
Materials Availability 
Plasmids generated in this study are available from the authors upon request. 
Data and Code Availability  
The published article includes all datasets generated or analyzed during this study. For some data 
analysis we used a custom code/algorithm implemented in IGOR Pro, as previously published (Di 
Rienzo and Annibale, 2016), (Serfling et al., 2019), (Bathe-Peters et al., 2020), which is available 
from the authors upon request.   
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
HEK-tsA201 cells (ECACC 96121229 from Sigma-Aldrich Chemie GmbH), indicated as 
HEK293 throughout the manuscript, were cultured in Dulbecco’s modified Eagle Medium 
(DMEM) with 4.5 g/L glucose (PAN biotech, Aidenbach, Germany), 10 % fetal bovine serum 
(Biochrom GmbH, Berlin, Germany), 100 U/ml penicillin, 100 µg/mL streptomycin (Pen/Strep, 
Gibco Life technologies, Carlsbad, CA, USA) and 2 mM-glutamine (PAN biotech, Aidenbach, 
Germany) at 37°C and 5% CO2. Cells were passaged in T75 flasks (SARSTEDT, Nümbrecht, 




mycoplasma contamination using MycoAlertTM Mycoplasma Detection Kit from Lonza (Basel, 
Switzerland). Cell lines were not contaminated with mycoplasma. 
For single-cell FRET measurements HEK293 cells were plated on 24 mm glass coverslips (Fisher 
Scientific GmbH, Waltham, MA, USA) in 6-well-dishes (SARSTEDT, Nümbrecht, Germany) at 
a density of approximately 2 x 105 cells/mL. Transfection of plasmids (600 ng for Epac1-camps-
based constructs, 300 ng for AKAR4-based constructs) was carried out 6 h after seeding using the 
Effectene Transfection Reagent (Qiagen GmbH, Venlo, Netherlands) according to the 
manufacturer’s instructions. After 18-24 h, cells were used for imaging. 
For FRET measurements in cytosolic preparations, HEK293 cells were plated on 100 mm dishes 
(SARSTEDT, Nümbrecht, Germany) to give a density of approximately 50-60%. 8 h later cells 
were transfected with a total amount of 20 µg cDNA (10 µg cDNA encoding the gene of interest 
and 10 µg pcDNA3) using calcium phosphate precipitation. 48 h after transfection, cells were used 
for experiments.   
METHOD DETAILS  
Synthesis and characterization of 8-F-cAMP 
The designed fluorogenic cAMP analogue 8-(2-(5(6)-carboxyfluoresceindiacetate)-
aminoethylthio)adenosine-3',5'-cyclic monophosphate (abbreviation: 8-FDA-cAMP) was custom-
synthesized by Biolog Life Science Institute, Bremen, Germany (details in Methods S1). The 
identity and purity of 8-FDA-cAMP were assessed with mass spectrometry and HPLC, 
respectively, by Biolog Life Science Institute, Bremen, Germany (details in Methods S1).  
8-F-cAMP (the de-esterified fluorescent analogue of the membrane-permeable prodrug 8-FDA-
cAMP) was used for the photophysical and biochemical characterization. To provide the 




spectra of 8-F-cAMP (details in Methods S1). To determine the binding affinity of 8-F-cAMP to 
its binding protein PKA regulatory subunit I alpha (PKA-RI), we performed steady state 
anisotropy measurements (details in Methods S1). To show that 8-F-cAMP activates downstream 
signaling, we used the PKA Colorimetric Activity Kit (ThermoFisher Scientific, Waltham, MA, 
USA) which reports on the activation of endogenous PKA in HEK293 cell lysates (details in 
Methods S1). To determine the stability of 8-F-cAMP towards hydrolysis by PDEs, we conducted 
PDE activity assays using a purified PDE from bovine brain and a colorimetric PDE assay 
(PDELightTM, Lonza) (details in Methods S1). 
 
cDNAs and biosensor construction  
The cDNA encoding PDE2A (NM_002599) was purchased from OriGene, Rockville, MD, USA. 
The AKAR4 plasmid (Depry et al., 2011)was a kind gift of Dr. Jin Zhang (UC San Diego, USA) 
and a plasmid encoding the IRES2 sequence was kindly provided by Dr. Gary Lewin (MDC Berlin, 
Germany). 
To generate Epac1-camps-SAH10-PDE4A1 (and Epac1-camps-SAH30-PDE4A1) the SAH10 
(and SAH30) linkers were PCR amplified from plasmids encoding systematic protein affinity 
strength modulation (SPASM) sensors published previously (Sivaramakrishnan and Spudich, 
2011), and BamHI and AscI restriction sites were introduced using the following set of primers  
(SAH10: #1: 5’-AAAAAAGGATCCGGAGAAGAGGAAGAGAAA-3’, #2: 5’-
AAAAAAGGCGCGCCCAGAGCCCTTCTTCTTGCGTTTTTC-3’, priming 
sequence underlined, restriction sites in italics; SAH30: #3: 5’-
AAAAAAAGGATCCGGAGAAGAGGAAGAGAAGAAG-3’, #4: 5’-




with BamHI and AscI and cloned in frame between Epac1-camps and PDE4A1 using a variant of 
Epac1-camps-PDE4A1 (Herget et al., 2008) as vector. To generate Epac1-camps-PDE2A3, 
Epac1-camps-PDE2cat (amino acids 578-941 from PDE2A3), and Epac1-camps-SAH30-
PDE2cat, the coding sequences of PDE2A3 and PDE2cat were PCR amplified and AscI and NotI 
restriction sites were inserted by using the following set of primers, respectively (PDE2A3: #5: 5’-
AAAAAAAGGCGCGCCGGGCAGGCATGCGGCCAC-3’, #6: 5’-
AAAAAAGCGGCCGCTCACTCAGCATCAAGGCT-3’; and PDE2cat: #7: 5’-
AAAAAAAGGCGCGCCTCCGACGATGAGTATACCAAACTT-3’, 6#). The respective PCR 
products were cut with AscI and NotI and cloned in frame into Epac1-camps-PDE4A1 and Epac1-
camps-SAH30-PDE4A1 where the PDE4A1 sequence was cut out with AscI and NotI. All 
constructs derived by restriction enzyme cloning were transformed and amplified in XL1-Blue 
competent E.coli (Agilent Technologies, Waldbronn, Germany).  
AKAR4-PDE4A1 and AKAR4-PDE2A3 were generated by Gibson assembly using Epac1-
camps-PDE4A1 and Epac1-camps-PDE2A3, respectively, as templates (Gibson et al., 2009).  To 
generate AKAR4-PDE4A1, AKAR4 was PCR amplified using a pair of primers (#8: 5’-
CTCACTATAGGGAGACCCAAGCTTTAAGGATCCCATGGTGAGCAAGGG-3’ ,#9: 5’-
CACCAAGGGCATGGATCCCTCGATGTTGTGGCGGATCTT-3’) and inserted upstream of 
PDE4A1 in its vector which was linearized with the following primers (#10: 5’-
AAGATCCGCCACAACATCGAGGGATCCATGCCCTTGGTG-3’, #11: 5’-
CCCTTGCTCACCATGGGATCCTTAAAGCTTGGGTCTCCCTATAGTGAG-3’). To 
generate AKAR4-PDE2A3, AKAR4 was PCR amplified using another pair of primers (#12: 5’-
GGGAGACCCAAGCTTAAGGATCCCATGGTGAGCAAG-3’, #13: 5’-




of PDE2A3 in its vector which was linearized with the following primers (#14: 5’-
ATCCGCCACAACATCGAGAGGCGCGCCGGGCAGGCATGCGGC-3’, #15: 5’-
CTTGCTCACCATGGGATCCTTAAGCTTGGGTCTCCCTAT-3’). 
To generate Epac1-camps-IRES2-PDE4A1, the IRES2 sequence was PCR amplified with the 
indicated primers (#16: 5’-
GACGAGCTGTACAAGTGAGGATCCGCCCCTCTCCCTCCCCCCCCCCTA-3’, #17: 5’-
GCAGAAGAAATCCACCAAGGGCATTGTGGCCATATTATCATCGTGTTT-3’) and 
inserted in frame in between Epac1-camps and PDE4A1 in the construct Epac1-camps-
PDE4A1 which was linearized with the following primers (#18: 5’-
AAACACGATGATAATATGGCCACAATGCCCTTGGTGGATTTCTTCTGC-3’, #19: 5’-
TAGGGGGGGGGGAGGGAGAGGGGCGGATCCTCACTTGTACAGCTCGTC-3’. Epac1-









C-3’). For assembly of the PCR products the Gibson Assembly® Master Mix (New England 
Biolabs GmbH, Frankfurt, Germany) was used according to the manufacturer’s instructions. All 




E.coli (New England Biolabs GmbH, Frankfurt, Germany).  
All sequences were validated by automated sequencing of each construct by Eurofins 
(Luxembourg, Luxembourg) or LGC (Teddington, UK). Confocal images of HEK293 cells 
expressing all FRET-based constructs are compiled in Figure S5.  
 
8-FDA-cAMP cell penetration assays 
8-FDA-cAMP and FDA cell penetration assays were performed using a 96-well plate reader 
(Neo2, Biotek, Bad Friedrichshall, Germany), measuring whole fluorescence emission per well at 
505 nm upon 488 nm excitation. 50,000 cells/well were seeded, and 24 wells were measured, in 
three replicates, for each experimental condition. Cells were kept in HBSS buffer, where 
spontaneous conversion of FDA and 8-FDA-cAMP to their fluorescent form is negligible. 
Confocal images of HEK293 cells loaded with either FDA or 8-FDA-cAMP are found in Figure 
S2B-C. 
Calibration compounds for diffusion measurements 
Fluorescein-labeled compounds of different molecular weight (fluorescein isothiocyanate-dextran 
of 20, 70kDa, and 250 kDa) were dissolved in water, and the pH was set to pH=9 by addition of 
NaOH. To pre-activate FDA into fluorescein, ester bonds in FDA were broken by incubation at 
37°C for 30 minutes at pH 9. Concentrations were determined by absorbance spectroscopy in a 
ThermoFisher Evolution300 spectrophotometer. Measurements were performed at a final 
compound concentration of 100 nM. Approximately 40 µL of solution were inserted into an 
imaging chamber formed by a #1.5 coverslip immobilized onto a glass slide by melting two parallel 





Collecting linescans in a confocal microscope 
Linescans were acquired in a Leica SP8 confocal microscope (Leica Microsystems, Wetzlar, 
Germany), with a resonant scan head allowing 12 kHz line rate. Excitation was achieved using a 
white light laser, at the wavelengths of 488 nm. Excitation power was set to 10% of the maximal 
laser output (0.3 mW at 488 nm), and 2∙106 lines were collected within the sample, with a length 
of 256 pixels and a pixel size of 50 nm. A 40x 1.4 NA objective was used. Detection was performed 
in photon counting mode using Leica hybrid detectors. For 8-FDA-cAMP linescan experiments 
cells were plated on 25 mm (#1.5) coverslips and loaded for 30 minutes with 100 nM 8-FDA-
cAMP at 37°C. Cells were then washed three times in Hank’s Balanced Salt Solution (HBSS) 
(Thermofisher) and imaged in HBSS. 
 
Extracting molecular diffusion 
Statistical analysis of the fluorescence fluctuations present in a sequence of images or a kymograph 
allows constructing a spatial-temporal correlation plot, containing the average single molecule 
transit times between any two arbitrary positions along the scan line (Ries et al., 2009, Hebert et 
al., 2005, Di Rienzo et al., 2013, Di Rienzo and Annibale, 2016). Such two-dimensional plots, 
namely Spatial-Temporal Image Correlation Spectroscopy (STICS) functions have two axes: a 
space and a time axis. The overall shape of the STICS function for diffusion is that of a ‘plume’, 
broadening in space as a function of time (Figures 1A, S1A, S1B and S1C). This broadening 
reflects the process of diffusion: the probability of finding a Brownian particle which is found at 
x=0 for time t=0 is a normal distribution of increasing variance as time elapses. The more rapid 
the broadening of the plume (Figures S1A, S1B, and S1C), the more rapid the molecular diffusion 




(i.e. broadening as a function of time) (Figure S1D). Vertical cross sections, known as average 
Pair Correlation functions, reflect the distribution of molecular transit times across a defined 
distance d (Figure S1G). These reflect the probability of finding a molecule at a given distance 
from its original position at time 0, after a time lag t. The position of the peak, reflecting the 
broadening of the STICS function, shifts to longer times as the diffusion coefficient decreases.  
The temporal resolution of the measurement is determined by how rapidly the subsequent 
acquisitions of the same area (or line) are performed. In our setup, taking advantage of resonant 
scanners operating at 12 kHz, we could reach a temporal resolution of about 80 µs.  
Determining faster (> 100 m2/s) diffusion is at the limit of this method, but it was possible to 
observe a convergence to previously measured cAMP diffusion values, viz. 135 ± 20 m2/s, by 
fitting progressively shorter time-lags. Furthermore, the distribution of rapid arrival times (Figure 
S2G) in forskolin/IBMX-stimulated cells further confirms the presence of a fast-moving 
component upon displacement, in the form of a peak at about 5 ms travel time over one µm.   
Model fitting to STICS functions 
Briefly, the 256 x 2∙106 kymograph is corrected for drifts and slow fluctuations using a random 
number addition detrending, within a moving window of approximately 250∙103 lines, which 
corresponds to about 20 s. The fast Fourier transform (FFT) and its complex conjugate were then 
calculated, and their product was inverse FFTed to yield the autocorrelation function of the 
kymograph, namely the STICS function. We used a custom algorithm written in IGOR Pro 
(WaveMetrics), as previously described (Serfling et al., 2019, Di Rienzo and Annibale, 2016). For 





𝐺(𝑥, 𝑡) =  
𝛾












With x and t being space and time, respectively, and 𝛾 the so-called gamma factor of the Point 
Spread Function (PSF) of the microscope, normally 0.35. N is the number of fluorescent molecules 
in the PSF, D the diffusion coefficient of the species and 𝜎0 the waist of the PSF (of the order of 
250-300 nm for the wavelength used). For each given t, eq. 1 can also be used for a line by line fit 
of the STICS function (as described in Figures S1D), yielding the MSDs reported in Figure S1E, 
as graphically highlighted in Figure S1F. 
In the case of two species displaying distinct concentrations and diffusion rates, the equation 
becomes (with 1 and 2 referring to each of the two species, respectively):  
𝐺2(𝑥, 𝑡) =  
𝛾






















Interpretation of MSD at multiple timescales 
When two species with distinct diffusion coefficients combine, e.g. a fast diffusing and a slow 
diffusing component/bound component, a fast broadening STICS function and a slow one overlap. 
Figure S2H and S2I illustrate how this reflects in terms of the measured STICS function and 
recovered MSD, respectively: a first rapid increase of MSD is followed by a decrease and again 
an increase, although at a slow pace. This should be interpreted in the following way: when the 
temporal resolution of the sampling is high enough, e.g. less than 10 ms as in Figure S2I, then 
rapid ‘jumps’ of the molecules can be appreciated. However, once the temporal resolution is lower, 




where the slower diffusing species dominates the MSD. This simulated plot represents the scenario 
observed in Figure 1 for the fsk/IBMX stimulated cells, where a fraction of the 8-F-cAMP diffuses 
very rapidly, on the background of a major fraction that still moves very slowly. 
Single-cell FRET measurements  
Transfected HEK293 cells were transferred to imaging chambers (AttofluorTM, ThermoFisher 
Scientifics), washed twice with FRET imaging buffer (144 mM NaCl, 5.4 mM KCl, 2 mM CaCl2 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany), 1 mM MgCl2 (AppliChem, Darmstadt, 
Germany), 10 mM HEPES (Sigma-Aldrich Chemie GmbH); pH = 7.3). FRET measurements were 
carried out at room temperature using an epifluorescence microscope (Leica DMi8 inverted 
microscope, Leica Microsystems, Wetzlar, Germany) equipped with an oil immersion objective 
(HC PL APO 40x/1.30, Leica Microsystems, Wetzlar, Germany), a dichroic beam splitter 
(T505lpxr, Visitron Systems, Puchheim, Germany), a high-speed polychromator (VisiChrome, 
Visitron Systems), a Xe-Lamp (75W, 5.7 A, Hamamatsu Photonics, Hamamatsu City, Japan), a 
camera system (Photometrics Prime 95B CMOS camera, Visitron systems) with an Optosplit II 
dual emission image splitter (Cairn, Edinburgh, Scotland, UK) with CFP 470/24 and YFP 535/30 
emission filters (Chroma Technology, Bellows Falls, VT, USA). Cells were brought into focus 
and regions of interest were drawn around single cells using the VisiView® 4.0 imaging software 
(Visitron Systems). Spatial homogeneity of the expression of the constructs was taken into account 
by ROI selection. In general, large ROIs containing most of the cell allow for averaging out any 
residual spatial heterogeneity within the cytosol. A time series of images was recorded every 5 
seconds upon 100 ms exposure to 436 nm light. After reaching a stable baseline, cells were 
stimulated with the β-adrenergic agonist isoproterenol (Iso, 10 µM), followed by specific PDE 




and PDE2A3 constructs). To reach maximal cAMP levels, a combination of fsk (10 µM) and 
IBMX (100 µM) were applied at the end of every experiment. Data from individual channels (CFP 
and YFP) were exported and corrected offline for background and bleedthrough (Borner et al., 
2011). Inverted FRET ratios (CFP/FRET) were calculated and normalized to baseline (average of 
10 data points before compound addition, set to 0% and fsk/IBMX (max cAMP response, set to 
100 %). After every experiment, direct YFP excitation at 505 nm (emission: 560 nm) was recorded 
to evaluate expression levels of the sensors.  
FRET measurements in cytosolic preparations 
Transfected HEK293 cells on a 10 cm plate (corresponding to approximately 1-1.5x107 cells) were 
washed twice with ice-cold Dulbecco’s Phosphate Buffered Saline (Sigma-Aldrich) and harvested 
in 300 µL lysis buffer (10 mM Tris-HCl, 10 mM MgCl2, pH 7.4) containing 1 mM PMSF and 
protease inhibitors (20 μg/mL trypsin inhibitor from soybean and 60 μg/mL benzamidine). Cells 
were lysed by homogenization (two rounds of 10 s each using an T8 Ultra-Turrax® homogenizer 
(IKA, Staufen, Germany)). Nuclei and cell debris were spun down by centrifugation (1000xg, 5 
min, 4°C). To obtain the cytosolic fraction, the supernatant was centrifuged again (100.000xg, 30 
min, 4°C). The resultant supernatants were transferred to a quartz cuvette and adjusted with 10 
mM Tris-HCl, 10 mM MgCl2 (pH 7.4) to comparable sensor densities (assessed by direct YFP 
excitation). Fluorescence emission spectra were recorded with a LS50B spectrometer 
(PerkinElmer Life Sciences, Waltham, MA, USA) at 436 nm excitation, and emission was 
measured between 460 and 550 nm after adding increasing concentrations of cAMP. 480/525 nm 
FRET emission ratios were calculated at different cAMP concentrations and fitted with a three-
parameter logistic function and normalized to the lower (absence of cAMP; set 0%) and upper 




Quantification of cAMP binding sites  
Cytosolic HEK293 cell preparations for the quantification of buffering capacities (Figure S4) were 
prepared as follows: HEK293 cells grown on a 10 cm dish, containing approximately 1 x 107 cells, 
were harvested in 300 µL binding buffer (20 mM MOPS, 150 mM NaCl, 0.005% CHAPS, pH7) 
containing 1mM PMSF and protease inhibitors (20 μg/mL trypsin inhibitor from soybean and 60 
μg/mL benzamidine) and cytosolic extracts were prepared according to the protocol described 
above (FRET measurements in cytosolic preparations).  Estimating an average cell volume of 1 pL per 
cell, the total cell volume of harvested cells (10 µL) is diluted 30 times (30x) by addition of 300 
µL binding buffer for harvesting. For anisotropy measurements, 0.5 mM IBMX were added and 
the cytosolic preparation was further diluted twice or 50 times with binding buffer, resulting in a 
60x or 1500x, respectively. Steady state anisotropy (from here on only referred to as ‘anisotropy’) 
as well as fluorescence excitation and emission spectra were measured on a Horiba Yobin-Yvon 
Fluoromax Plus spectrophotometer using the appropriate routine of the FluorEssence software. 8-
F-cAMP and fluorescein were both excited at 485 nm and fluorescence was measured at 535 nm. 
Slit width was 5 nm for both excitation and emission. 600 µL of solution were pipetted in a quartz 
Cuvette (Thorlabs). Integration time was set to between 1-10 s. Fluorescence intensity I was 
measured along all polarizations (Ihh, Ihv, Ivv, Ivh) and anisotropy r was calculated according to the 










When imaging scattering solutions (such as cytosolic cell extracts) anisotropy values were 
corrected to those of the pure solution - without any fluorescent dye added - by subtracting each 





Molecular brightness experiments were performed as previously reported (Annibale and Lohse, 
2020). Briefly, movies of 100 frames of individual cells were acquired using a Laser Scanning 
Confocal Microscope SP8 (Leica), at a speed of 400 Hz, with an excitation power of 3% at 514 
nm, corresponding to a few µW in the sample plane. Detection was performed using photon 
counting detectors (Leica HyD), in the spectral range 520-600 nm. Molecular brightness values 
per pixel dwell time were calculated for each pixel, and the average cytosolic value from each 
individual cell is reported, after converting to photon counts/s.  Briefly, molecular brightness is 
calculated by measuring the variance 𝜎 of the photon counts over time for each pixel by the average 
intensity value k, according to the formula: 𝜎2/k. The values of all the pixel within a homogeneous 
area of the cytosol are then averaged together. 
Confocal microscopy 
Fluorescence microscopy experiments were performed either on a Leica SP8 Confocal 
Microscopes, using HyD photon counting detectors and a White Laser light source to achieve 
excitation at the desired wavelengths (488 nm, and 514 nm). Emission was collected in the 500-
600 nm and 520-600 nm range respectively. A 40x 1.3 NA objective was used, and the electronic 
zoom was set to achieve a pixel size of 50 nm. 
Biophysical model of cAMP signaling at the nanoscale 
We have modeled cAMP reaction/diffusion behavior in the cell, in particular in the vicinity of a 
PDE, according to the classical treatment original provided by Smoluchowski(Smoluchowski, 
1916) (details in Methods S2). Here, the catalytic site of the PDE is seen as a sphere of radius R 
and cAMP as a species diffusing (with a diffusion coefficient D) in its vicinity, assuming that no 




concentration [cAMP], and in all our calculations the diffusion coefficient D refers to the free 
cAMP diffusion rate. This assumption is justified as we are interested in length scales of the order 
30 nm, which is well below the average distance between two PDEs at physiological 
concentrations. Once the cAMP reaches the surfaces of the sphere, a degradation reaction takes 
place, making the PDE effectively a spherical sink characterized by a flux I of molecules degraded 
per unit time, in units of mol/s (or nmol/s or µmol/s). The requirement that the total flux of free 









 Equation 4 
Which allows to solve the appropriate reaction-diffusion equation in spherical coordinates, leading 







. Equation 5 
The equation can also be written in terms of the radius R0 where the concentration would be 0, i.e. 
the radius of a perfect absorber. 
     0
bulk
R





 Equation 6 
QUANTIFICATION AND STATISTICAL ANALYSIS  
Data analysis was performed using GraphPad Prism software 7.0 (GraphPad Software, San Diego, 
USA) and IGOR Pro 7 (Wavemetrics, Lake Oswego, USA). Normal distribution of data points 
was tested in every data set using D’Agostino-Pearson omnibus normality test before evaluating 
significance. When comparing two populations, a Student’s t-test was used. When comparing three 
or more populations, a parametric one-way ANOVA with Tukey’s multiple comparison test was 







followed: ns (not significant) *: p≤0.05; **: p≤0.01; ***: p≤0.001, ****: p≤0.0001. Data are 
represented throughout as mean ± error (s.e.m., SD, or 95% confidence intervals), plus – where 
appropriate – as scatter plots of individual results. More details about statistics, e.g. repetition of 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Bacterial and Virus Strains  
NEB® 5-alpha Competent E.coli (High Efficiency) New England Biolabs Cat#: C2987 
XL1-Blue Competent Cells Agilent Cat#: 200249 
Chemicals, Peptides, and Recombinant Proteins 
(-)-Isoproterenol hydrochloride Sigma-Aldrich  
Cat#: I6504; CAS: 
5984-95-2  
3-isobutyl-1-methylxanthin (IBMX) Sigma-Aldrich  
Cat#: I5879; CAS: 
28822-58-4 
8-FDA-cAMP  
BIOLOG Life Science 
Institute 
N/A 
Adenosine 3′,5′-cyclic monophosphate sodium salt 
monohydrate (cAMP) 
Sigma-Aldrich  
Cat#: A6885; CAS: 
37839-81-9 
BAY 60-7550  Cayman Chemical  
Cat#: 10011135; 
CAS: 439083-90-6 
Benzamidine Sigma-Aldrich  
Cat#: 12072; CAS: 
618-39-3 
CHAPS Avanti Polar Lipids 
Cat#: 850500P; 
CAS: 75621-03-3 
Effectene Transfection Reagent  Qiagen  Cat#: 301427 
Fluorescein ThermoFisher Scientific  
Cat#: 10700795; 
CAS: 2321-07-5 
Fluorescein diacetate Sigma-Aldrich  
Cat#: F7378 CAS: 
596-09-8 
Fluorescein isothiocyanate-dextran 20 kDa Sigma-Aldrich  
Cat#: FD20; CAS: 
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Fluorescein isothiocyanate-dextran 250 kDa Sigma-Aldrich  
Cat#: FD250S; CAS: 
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Gibson Assembly® Master Mix 
New England Biolabs  
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Cat#: E2611 
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Cat#: P7626; CAS: 
329-98-6 
Phosphodiesterase, 3′,5′-cyclic-nucleotide-specific from 
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Sigma-Aldrich  
Cat#: P9529; CAS: 
9040-59-9 
Purified PKA RIalpha, human Biaffin GmbH&co KG 
Cat#: PK-PKA-
R1A025  
Roflumilast  Tocris Bioscience  
Cat#: 6641; CAS: 
162401-32-3 
Trypsin inhibitor from soybean Sigma-Aldrich  
Cat#: T9003; CAS: 
9035-81-8 
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Table S1. cAMP diffusion coefficients (in µm2/s) in living cells reported in the literature, 




D Technique  
5 Raster Image Correlation Spectroscopy, fluorescently labeled cAMP 
(Pharos450-cAMP)  
Agarwal et al., 2016 
10 Raster Image Correlation Spectroscopy, fluorescently labeled cAMP 
(Pharos450-cAMP)  
Agarwal et al., 2016 
32 FRET H187, stimulation with microfluidic device, consideration of PDE 
activity  
Richards et al., 2016 
136 FRET HCN2-camps, stimulation with patch pipette, isoprenaline  Nikolaev et al., 2006 
270 CNG channel currents, injection of cAMP with a patch pipette  Chen et al., 1999 
330 cAMP activated sodium current/injection of cAMP with a patch pipette  Huang et al., 1993 
487 FRET Epac1-camps, stimulation with patch pipette, isoprenaline  Nikolaev et al., 2004 
780 FRET PKA dissociation, microinjection of cAMP  Bacskai et al., 1993 
Table S1, Table S2, Methods S1, Methods S2






























Methods S1. Synthesis and characterization of the novel fluorogenic cAMP 
analogue 8-FDA-cAMP, Related to Figures 1 and 2 and STAR Methods. 
 
1) Synthesis and characterization of 8-FDA-cAMP 
The designed fluorogenic cAMP analog 8-(2-(5(6)-carboxyfluoresceindiacetate)-
aminoethylthio)adenosine-3',5'-cyclic monophosphate (abbreviation: 8-FDA-cAMP, Methods 
S1 Figure 1) was custom-synthesized by Biolog Life Science Institute, Bremen, Germany. The 
synthesis was initiated by the following two compounds: 5-(and 6)-carboxyfluorescein 
diacetate, succinimidyl ester (CAS: 150347-59-4) and 8-AET-cAMP (Biolog Life Science 
Institute, Bremen, Germany; Cat-No.: A 141). It should be noted that 5-(and 6)-
carboxyfluorescein diacetate, succinimidyl ester is a mixture of two isomeric compounds and 
only available in this format. This, by definition, results in a mixture of two isomers of 8-FDA-
cAMP, as indicated in the structure (Methods S1, Figure 1a).  
The identity of 8-FDA-cAMP was assessed by mass spectrometry (ESI-MS) on a Bruker 
Esquire 600 instrument in methanol/water (1:1) and addition of formic acid. ESI-MS (m/z): 
[M + H]+ calculated for C37H31N6O14PS: 847.14, found: 847.2. [M - H]+ calculated for 
C37H31N6O14PS: 845.14, found: 845.2.  
To assess the purity of 8-FDA-cAMP, HPLC was performed on a Merck/Hitachi device 
equipped with a L-6200 intelligent pump, a L-4250 UV-VIS detector (wavelength 276 nm) and 
a D-7500 integrator. The injection volume was 5 µl. Column: YMC ODS-A 120-11, RP-18; 
250 x 4 mm; Mobile phase: 32 % acetonitrile, 50 mM NaH2PO4, pH 5, flow 1.5 mL/min, room 
temperature. The chromatogram is displayed in Methods S1, Figure 1 bottom. The peaks at 
6.41 and 6.88 minutes correspond to the two isomers of 8-FDA-cAMP. The peak at 3.12 
minutes corresponds to the spontaneously de-esterified compound 8-(2-(5(6)-
carboxyfluorescein)-aminoethylthio)adenosine-3',5'-cyclic monophosphate (abbreviation: 8-
 2 
F-cAMP). Based on this data, the purity of 8-FDA-cAMP used in our study can be estimated 
as 95.6 %. We shall further note that 8-F-cAMP is non cell-membrane permeable, hence, any 
residual fraction of 8-F-cAMP present in the original stock will not enter the cell, and therefore 




Methods S1 Figure 1: Molecular structure of 8-FDA-cAMP and HPLC chromatogram. 
 
2) Photophysical and biochemical characterization of 8-F-cAMP 
8-FDA-cAMP is cell-permeable and a substrate for cellular esterases which hydrolyze the two 
ester bonds per molecule, giving rise to the fluorescent cAMP analogue 8-F-cAMP in intact 
cells (Figures 1 and S2) and cytosolic preparations (Figure 2).  
We provide here a photophysical and biochemical characterization of 8-F-cAMP. Based on 
four lines of experimental evidence we show the absorption, excitation, and emission spectra 
of 8-F-cAMP, binding of 8-F-cAMP to purified PKA regulatory subunit I alpha (PKA-RIa), 
 3 
activation of endogenous PKA holoenzymes in lysates of HEK293 cells, and the stability 
towards hydrolysis of 8-F-cAMP by PDEs, using a purified PDE from bovine brain. 
For all in vitro experiments described below, we used the de-esterified, fluorescent version of 
8-FDA-cAMP, i.e. 8-F-cAMP. To generate 8-F-cAMP in vitro, a stock solution of 8-FDA-
cAMP was diluted in 50 mM TRIS (pH8) and incubated at 30°C for 48 h. This leads to 
quantitative hydrolysis of the ester bonds as verified by absorption spectroscopy. 
 
3) Photophysical characteristics of 8-F-cAMP 
 
Absorbance, excitation, and emission spectra of 1 µM 8-F-cAMP were measured on an 
Evolution 350 UV/Vis Spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA), 
















Methods S1 Figure 2: Photophysical characteristics of 8-F-cAMP. Absorbance, excitation and emission 
spectra of 1 µM 8-F-cAMP diluted in 50 mM TRIS pH8. The measured extinction coefficient is 80,000 M-1cm-1 
approximately 90% of that of pure fluorescein at comparable pH. The profile of absorption, excitation and 
emission spectra agrees with that of fluorescein itself which is shown as dashed lines (fluorescein in water at pH 
9). 
4) Affinities of 8-F-cAMP and cAMP to purified PKA-RIa 
All binding assays were done by steady-state anisotropy, where binding is monitored by 
decreases in anisotropy of the bound vs. the free 8-F-cAMP. Purified PKA-RIa was obtained 












































(20 mM MOPS (pH 7) (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 150 mM NaCl 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany), 0.005 % CHAPS (Avanti Polar Lipids, 
Inc, Alabaster, AL, USA)). Saturation binding experiments were conducted in PKA binding 
buffer using 3 nM 8-F-cAMP as tracer and increasing concentrations of purified PKA-RIa. 
Samples were incubated for 4 min at room temperature and steady-state anisotropy was 
measured (STAR Methods). For competition binding experiments 3 nM 8-F-cAMP was 
preincubated with increasing concentrations of cAMP in PKA binding buffer. After 
determining the basal steady-state anisotropy for every single cAMP/8-F-cAMP mixture (i.e. 
anisotropy of free 8-F-cAMP), 6 nM purified PKA-RIa was added, incubated for 4 min at 
room temperature and then PKA-bound steady-state anisotropy was measured.  
Methods S1 Figure 3: 8-F-cAMP and cAMP have the same affinity to PKA-RIa. (A) Saturation binding of 
indicated concentrations of purified PKA-RIa to 3 nM 8-F-cAMP reveals low nanomolar affinity of  
8-F-cAMP to PKA-RIa (KD(8-F-cAMP) = 7.5 nM). (B) Heterologous competition binding (cAMP vs 8-F-cAMP) 
experiments were performed to quantify the affinity of cAMP to purified PKA-RIa. IC50 values were Cheng-
Prusoff corrected to give a cAMP affinity of KD(cAMP) = 7.8 nM. Data in (A) and (B) are means ± SD from at 
least three independent experiments. 
 
 
























5) Quantification of PKA activity stimulated by 8-F-cAMP and cAMP in cell lysates 
To compare the activation characteristics of 8-F-cAMP and cAMP, we measured the activity 
of endogenous PKA in HEK293 cell lysates using the PKA Colorimetric Activity Kit 
(ThermoFisher Scientific, Waltham, MA, USA). HEK293 cell lysates were prepared according 
to manufacturer’s instructions. Lysates were stimulated with increasing concentrations of 
cAMP or 8-F-cAMP in the presence of 0.5 mM IBMX. PKA activity was normalized to the 
effect induced by the highest cAMP concentration. Data were fitted with a three parameters 
logistic function to yield activation constants for half maximal PKA activation (Methods S1 
Figure 4). Our data demonstrate that 8-F-cAMP is a potent and efficacious activator of PKA, 












Methods S1 Figure 4: 8-F-cAMP stimulates PKA activity. PKA activity was assessed in HEK293 cell lysates 
in response to increasing concentrations of cAMP and 8-FDA-cAMP in the presence of 0.5 mM IBMX. cAMP 
(black) and 8-F-cAMP (red) stimulate PKA activity in the nanomolar range: EC50(cAMP) = 77.3 nM, EC50(8-F-
cAMP) = 29.6 nM. Data are means ± SD from three independent experiments. 
 
6) Stability of 8-F-cAMP against hydrolysis by phosphodiesterases 
To compare PDE substrate characteristics of cAMP and 8-F-cAMP, we conducted PDE 
activity assays with purified PDE from bovine brain (PDE1A; P9529 Sigma-Aldrich Chemie 





















GmbH, Steinheim, Germany). Increasing concentrations of cAMP (mixed with fluorescein 
(ThermoFisher Scientific, Waltham, MA, USA) at a 1:1 molar ratio) or 8-F-cAMP were added 
to a mixture of 1 nM PDE and AMP detection reagent (PDELightTM, Lonza) in PDE assay 
buffer (20 mM TRIS, pH 8, 20 mM imidazole (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany), 3 mM MgCl2, 0.2 mg/mL BSA (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany)) at room temperature. Immediately after substrate addition, luminescence was 
measured every 15 s for 30 min (integration time: 0.1 s) in a plate reader (Neo2, Biotek, Bad 
Friedrichshall, Germany). The slopes of the initial linear increases in luminescence were 
plotted against substrate concentrations to give Michaelis-Menten kinetics (Methods S1 
Figure 5). In contrast to cAMP, 8-F-cAMP is not a PDE substrate up to >600 µM. After 
completion of kinetic experiments, 300 µM cAMP was added to 8-F-cAMP samples and 
luminescence was measured again. The resultant inhibition shows that 8-F-cAMP binds to 
PDE1A but does not serve as a substrate.  
   
Methods S1 Figure 5: 8-F-cAMP is not a PDE substrate. (A, B) PDE activity was measured by incubating  
1 nM PDE1A with increasing concentrations of cAMP (A) or 8-F-cAMP (B) for 30 minutes. Slopes of linear 
increases in luminescence (measured as relative light units RLU/s) were normalized to maximal turnover and 
plotted against substrate concentration to give kinetic profiles. 8-F-cAMP is not a PDE substrate (B). (C) 8-F-
cAMP inhibits PDE1A activity. Shown are total luminescence values collected within 30 minutes after addition 
of 300 µM cAMP. Indicated 8-F-cAMP concentrations were pre-incubated with 1 nM PDE1A for 30 minutes at 
room temperature. Data are means ± SD of three independent experiments conducted in duplicate. 


































































Methods S2. Quantitative aspects of cAMP compartmentation at the 
nanoscale, Related to Figure 7 and STAR Methods. 
1. Introduction 
Our experimental data on diffusion (Figures 1 and 2) show that cAMP dynamics are 
substantially reduced as compared to free diffusion (Figure 1). That indicates that cAMP in 
cells is strongly buffered, which is analogous to what has been observed and modelled for Ca2+ 
more than 25 years ago (Wagner and Keizer, 1994). In essence, cAMP is mostly bound to 
cAMP binding proteins, which are present in cytosol (Figure 2 and Figure S4) as well as bound 
to cellular structures. This buffering results in a relatively low concentration of free cAMP, 
which allows PDEs to create nanometer-sized cAMP gradients where the cAMP concentration 
at the PDE is decreased to a range which is sufficient to suppress local PKA activation. Here, 
we would like to delineate some quantitative aspects of cAMP compartmentation at the 
nanoscale, using the data that we obtained experimentally for PDE4A1. 
 
2. cAMP gradients in the vicinity of PDE molecules  
At a given cellular concentration of PDEs of x in units of nM, the average distance between two 
PDE molecules is at least , which entails 0.82 µm at 3 nM. We are interested in 
length scales below 30 nm in this section and therefore consider a single PDE molecule and its 
vicinity and assume there is no AC molecule close by. This enables us to use the Smoluchowski 
model representing the catalytic site of the PDE as a diffusing sphere and cAMP as a species 
diffusing in its vicinity (Rice, 1985, Smoluchowski, 1916). This catalytic site causes the 
turnover of a given number of cAMP molecules per second, which we denote as the flux I. We 
consider stationary states as justified by the duration of measurements. Note that the un-
buffered diffusion coefficient for cAMP and not the effective diffusion coefficient enters the 
31.186µm / x
stationary equations on the length scale of a few tens of nm. The PDE enters by the requirement 
that the total flux of free cAMP towards the PDE at the radius R of the catalytic site equals the 
turnover I (Rice, 1985) 
  
The concentration of free cAMP at a large distance from the PDE molecule is the spatially 
averaged cAMP concentration called [cAMP]bulk. The stationary solution of the diffusion 
equation in spherical coordinates with the PDE in the center is 
  (1) 
with r denoting the radius coordinate. The concentration at the encounter radius s is 
    (2) 
The PDE would be a perfect absorber ([cAMP](s)=0) with 
  (3) 
where we used s=1 nm, [cAMP]bulk=0.575 µM (Table 1) and D=100 µm2s-1. 
 
3. Estimation of the spatial concentration profile around PDE4A1 deduced from FRET 
experiments in cytosolic preparations and in intact cells 
If the concentration of Epac1-PDE4A1 molecules in cytosolic preparations is not too large, the 
concentration profile around the individual molecules also obeys the (1-1/r)-dependency of Eq. 
(1). Above, we have written the profile in terms of turnover I and the diffusion coefficient D. 
We can also write it in terms of the radius R0 where the concentration would be 0, if the profile 
reached down to R0: 
2
r R
















bulkI 4 D [cAMP] 435s ,
-³ p s =
  
We denote the distance between the catalytic site of PDE4A1 and the sensor’s binding site 
with Rsens and obtain for the concentration seen by the sensor 
 
The fluorescence we see in cells expressing Epac1-PDE4A1 is 
  
In intact cells we can write for the concentration seen by the sensor 
 
Since we measure cAMP concentrations (Figures 3, 4) and know the EC50 values of the sensors 
for cAMP, we can calculate and compare the values from the data obtained from cytosolic 
preparations and intact cells. Table 1 lists the intracellular cAMP concentration estimated from 
Figure 3. Based on these values, Table 2 lists the estimates for . 
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Table 1 Ranges for concentrations of free cAMP at the sensor estimated from Figure 3. 
 
Table 2 Comparison of concentration ratios in cytosolic preparations and in intact cells using 
the intracellular concentrations from Table 1. 
  
 





6.06 control PDE4A1 
Epac1camps-
PDE4A1  
25.02 0.242 0.270 
Epac1-camps-
SAH10-PDE4A1 
7.20 0.842 0.901 
Epac1-camps + 
PDE2cat 
5.62 control PDE2cat 
Epac1-camps-
PDE2cat  
37.2 0.151 0.363 
Epac1-camps-
SAH30-PDE2cat 




The ratio of bulk concentration to local concentration at PDE4A1 dimers in cytosolic 





















cAMP R EC R1
cAMP EC R
= -!
 Average (µM) Min (µM) Max (µM) 
cAMP (Epac1 + PDE4A1) 0.575 0.468 0.692 
cAMP (Epac1-PDE4A1 tethered) 0.151 0.120 0.191 
cAMP (Epac1-SAH10-PDE4A1): 0.518 0.423 0.616 
 
We obtain from Eq. (2)  
 . 
Taking the concentrations at the sensor as estimates for [cAMP](s) and with D=100 µm2s-1, s= 
1 nm, [cAMP]bulk=0.575 µM and [cAMP](s)=0.151 µM (Table 1) we obtain I= 320 s-1, i.e. 
160 s-1 per PDE4A1 monomer, given that we find PDE4A1 in cells predominantly as dimers. 
With the values in the Min and Max columns of Table 1 we obtain 263 s-1 and 379 s-1, 
respectively, as dimer turnover rates.  
Based on our FRET data in Figure 3, we can estimate the catalytic activity of PDE4A1 in intact 
cells. PDE4A1 activity compensates for isoproterenol-induced cAMP production in the 
stationary state. The rise of [cAMP] upon PDE4A1 inhibition (with roflumilast) approximately 
equals the rate of cAMP degradation before inhibition. We have determined the rate of the 
increase in free [cAMP] upon inhibition of PDE4A1 tethered to Epac1-camps (Figure 3E) with 
roflumilast to be in the range of 1µM/s. We also estimated the concentration of buffering sites 
B in cells to be in the range of 7.5-30 µM (Figure S4), with a dissociation constant KB of 0.1-
0.5 µM. Our estimate of the PDE4A1 dimer concentration is 30-100 nM (Figure S7). In line 
with the above estimate for the PDE4A1 dimer turnover based on the Smoluchowski model, 
we obtain here also 320 s-1 with B = 20 µM, KB = 0.5 µM and 30 nM PDE4A1. 
[ ] [ ]( )( )bulkI 4 D cAMP cAMP= p s - s
Figure S1 Click here to access/download;Supplemental Figure;Figure
S1.pdf
Figure S2 Click here to access/download;Supplemental Figure;Figure
S2.pdf
Figure S3 Click here to access/download;Supplemental Figure;Figure
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60x diluted cytosol 8-F-cAMP
1500x diluted cytosol 8-F-cAMP
60x diluted cytosol Fluorescein
A
nisotropy Fluorescein
Figure S4 Click here to access/download;Supplemental Figure;Figure
S4.pdf
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